Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally

Affiliations

• ¹ Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCLHospitals NHS Foundation Trust, London, UK. Electronic address: a.i.zumla@gmail.com.
• ² Division of Virology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge UK and School of Public Health, University of Makeni, Sierra Leone. Electronic address: ig299@cam.ac.uk.
• ³ Country and Inter-country Support, Office of the Regional Director, WHO- AFRO, Brazzaville, Republic of Congo. Electronic address: kasolof@who.int.
• ⁴ Fondation Congolaise pour la Recherche Médicale and University Marien Ngouabi, Brazzaville, Republic of Congo, and Institute for Tropical Medicine, University of Tübingen, Germany. Electronic address: fntoumi@fcrm-congo.com.
• ⁵ GlaxoSmithKline Vaccines, R&D Asia-Pacific, Gateway West, Singapore. Electronic address: philippe.x.buchy@gsk.com.
• ⁶ UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: matthew.bates@ucl.ac.uk.
• ⁷ Special Infectious Agents Unit, King Fahd Medical Research Centre, and Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. Electronic address: eazhar@kau.edu.sa.
• ⁸ The Wellcome Trust Sanger Institute, Cambridge, UK. Electronic address: mc13@sanger.ac.uk.
• ⁹ University of Aarhus, Denmark and The Royal Hospital, Muscat, Oman. Electronic address: eskildp@dadlnet.dk.